Registration statement for securities of certain foreign private issuers
Cover
Document And Entity Information
Financial Statements
Condensed Consolidated Balance Sheets
Condensed Consolidated Balance Sheets (Parentheticals)
Condensed Consolidated Statements of Comprehensive Loss (Unaudited)
Condensed Consolidated Statements of Comprehensive Loss (Unaudited) (Parentheticals)
Condensed Consolidated Statements of Shareholders' Equity (Unaudited)
Condensed Consolidated Statements of Shareholders' Equity (Unaudited) (Parentheticals)
Condensed Consolidated Statements of Cash Flows (Unaudited)
Notes to Financial Statements
General
Significant Accounting Policies
Unaudited Condensed Financial Statements
Fair Value Measurements
Deferred Revenues
Net Loss Per Share
Subsequent Events
Other Accounts Receivable and Prepaid Expenses
Short-Term Investment
Property, Plant and Equipment, Net
Other Accounts Payable
Contingent Liabilities and Commitments
Shareholders' Equity
Share-Based Payment Transactions
Leases
Finance Income (Expense), Net
Taxes on Income
Transactions with Related Parties
Accounting Policies
Accounting Policies, by Policy (Policies)
Notes Tables
Significant Accounting Policies (Tables)
Fair Value Measurements (Tables)
Other Accounts Receivable and Prepaid Expenses (Tables)
Property, Plant and Equipment, Net (Tables)
Other Accounts Payable (Tables)
Shareholders' Equity (Tables)
Share-Based Payment Transactions (Tables)
Leases (Tables)
Finance Income (Expense), Net (Tables)
Taxes on Income (Tables)
Notes Details
General (Details)
Significant Accounting Policies (Details)
Fair Value Measurements (Details) - Schedule of financial assets and liabilities measured at fair value on a recurring basis
Deferred Revenues (Details)
Net Loss Per Share (Details)
Subsequent Events (Details)
Significant Accounting Policies (Details) - Schedule of property, plant and equipment
Significant Accounting Policies (Details) - Schedule of major customer data as a percentage of total revenues
Other Accounts Receivable and Prepaid Expenses (Details) - Schedule of other accounts receivable and prepaid expenses
Short-Term Investment (Details)
Property, Plant and Equipment, Net (Details)
Property, Plant and Equipment, Net (Details) - Schedule of property, plant and equipment, net
Other Accounts Payable (Details) - Schedule of other accounts payable
Fair Value Measurements (Details) - Schedule of financial assets and liabilities measured at fair value on a recurring basis
Contingent Liabilities and Commitments (Details)
Shareholders' Equity (Details)
Shareholders' Equity (Details) - Schedule of information regarding outstanding warrants to purchase shares
Share-Based Payment Transactions (Details)
Share-Based Payment Transactions (Details) - Schedule of expenses
Share-Based Payment Transactions (Details) - Schedule of estimated using the binomial option pricing model
Share-Based Payment Transactions (Details) - Schedule of weighted average exercise prices and modification in option plans of employees
Share-Based Payment Transactions (Details) - Schedule of options outstanding classified by exercise price
Leases (Details)
Leases (Details) - Schedule of lease expense and supplemental cash flow information related to leases and weighted average remaining lease terms and discount rate
Leases (Details) - Schedule of maturities of lease liabilities
Finance Income (Expense), Net (Details) - Schedule of components of finance (income)
Taxes on Income (Details)
Taxes on Income (Details) - Schedule of deferred tax assets and liabilities
Transactions with Related Parties (Details)
Significant Accounting Policies (Details) - Schedule of major customer data as a percentage of total revenues
v3.22.4
Significant Accounting Policies (Details) - Schedule of major customer data as a percentage of total revenues
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Significant Accounting Policies (Details) - Schedule of major customer data as a percentage of total revenues [Line Items]
Total revenues
100.00%
100.00%
Cipher Pharmaceuticals [Member]
Significant Accounting Policies (Details) - Schedule of major customer data as a percentage of total revenues [Line Items]
Total revenues
12.00%
20.00%
Chong Kun Dang Pharmaceuticals Corp [Member]
Significant Accounting Policies (Details) - Schedule of major customer data as a percentage of total revenues [Line Items]
Total revenues
24.00%
45.00%
Gebro Holding GmBH [Member]
Significant Accounting Policies (Details) - Schedule of major customer data as a percentage of total revenues [Line Items]
Total revenues
23.00%
35.00%
Ewopharma AG [Member]
Significant Accounting Policies (Details) - Schedule of major customer data as a percentage of total revenues [Line Items]
Total revenues
41.00%
X
- Definition
Revenue contract with customer.
+ References
No definition available.
+ Details
Name:
canf_RevenueContractWithCustomer
Namespace Prefix:
canf_
Data Type:
dtr:percentItemType
Balance Type:
na
Period Type:
duration
X
- References
No definition available.
+ Details
Name:
canf_SignificantAccountingPoliciesDetailsScheduleofmajorcustomerdataasapercentageoftotalrevenuesLineItems
Namespace Prefix:
canf_
Data Type:
xbrli:stringItemType
Balance Type:
na
Period Type:
duration
X
- Details
Name:
srt_MajorCustomersAxis=canf_CipherPharmaceuticalsMember
Namespace Prefix:
Data Type:
na
Balance Type:
Period Type:
X
- Details
Name:
srt_MajorCustomersAxis=canf_ChongKunDangPharmaceuticalsCorpMember
Namespace Prefix:
Data Type:
na
Balance Type:
Period Type:
X
- Details
Name:
srt_MajorCustomersAxis=canf_GebroHoldingGmBHMember
Namespace Prefix:
Data Type:
na
Balance Type:
Period Type:
X
- Details
Name:
srt_MajorCustomersAxis=canf_EwopharmaAGMember
Namespace Prefix:
Data Type:
na
Balance Type:
Period Type: